Targeting ADRB2 enhances sensitivity of non-small cell lung cancer to VEGFR2 tyrosine kinase inhibitors
Yingzhuo Xu(Union Hospital), Gang Wu(Union Hospital)
Cited by 24
Related Papers
The role of sema4D in vasculogenic mimicry formation in non‐small cell lung cancer and the underlying mechanisms
|International Journal of Cancer|2018|62
Cardamonin induces ROS-mediated G2/M phase arrest and apoptosis through inhibition of NF-κB pathway in nasopharyngeal carcinoma
|Cell Death and Disease|2017|53
Anticancer activity of SAHA, a potent histone deacetylase inhibitor, in NCI-H460 human large-cell lung carcinoma cells in vitro and in vivo
|International Journal of Oncology|2013|31
PAK6 promotes cervical cancer progression through activation of the Wnt/β‑catenin signaling pathway
|Oncology Letters|2020|29
REV1 promotes lung tumorigenesis by activating the Rad18/SERTAD2 axis
|Cell Death and Disease|2022|29